Researchers at the Icahn School of Medicine at Mount Sinai have developed a first-of-its-kind mRNA system that switches on ...
Recursion Pharma, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral ...
Celecoxib improves disease-free and overall survival in ctDNA-positive stage III colon cancer patients when combined with ...
But when Trefzger went under the knife for facial feminization surgery, she had a stroke that caused blindness in her left ...
A woman on clozapine develops severe gastrointestinal hypomotility that progresses to toxic megacolon and multiorgan failure, ...
CAR-T stands for Chimeric Antigen Receptor T-cell therapy. Doctors harvest the patient’s T cells, the soldiers of the immune ...
For more than 20 years, women entering menopause were told to be afraid of hormone replacement therapy. Headlines warned of ...
A study identified two key genes (CTNNA1 and BCL2L13) as suppressors in spread of colorectal cancer, revealing new strategies ...
In a major step toward a precision therapy for Clostridioides difficile (C. diff) infection, researchers at The Hospital for ...
Researchers at the Icahn School of Medicine at Mount Sinai have developed a first-of-its-kind mRNA system that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results